PubMed · 2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

Wadden TA, Bailey TS, Billings LK, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.

JAMA

Source: https://pubmed.ncbi.nlm.nih.gov/33755728/

Last reviewed . By the PeptIQ team.

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.